Establishing Reliable
Biomarkers of Aging
for Longevity Interventions.
Advancing consensus and standards in geroscience through collaboration and open science.
Our Mission:
To support the geroscience community by creating standardized, clinically validated ways to measure aging and assess intervention outcomes, providing the field with the tools it needs to turn longevity interventions into safe and effective therapies.
2025 Biomarkers of Aging Conference
Thank you for joining us in Boston!
We’ll see you in 2026!
Our Programs:
We achieve our mission through open science, global collaboration,
and the sharing of critical data, tools, and insights. Learn more about our programs below.
-
Our 2-day, in-person annual Conference at the Joseph B. Martin Conference Center at Harvard Medical School in Boston, featuring cutting-edge academic science of biomarkers of aging as well as translational, clinical and regulatory aspects of biomarkers of aging featuring the world’s leading academic and industry scientists.
Learn more. -
We bring together leading researchers and stakeholders in the geroscience field to build and publish consensus roadmaps and standards for the systematic development and validation of biomarkers of aging.
-
A first-of-its-kind, open source library designed for the evaluation and unified validation of biomarkers of aging, and contains many curated and harmonized large, high-quality omics and health datasets.
Learn more. -
Our Biomarkers of Aging Challenge stimulates innovation and collaboration in the development of next-generation biomarkers that are highly predictive of chronological age, mortality, and multi-morbidity.
-
A longitudinal multi-modal deep-profiling study leverages community-based cohorts and state-of-the-art molecular and functional profiling to explore how aging affects us at molecular and functional levels, shedding light on the changes driving functional decline.
A global, collaborative geroscience community.
From scholars and healthcare practitioners to longevity industry pioneers and regulatory leaders, together we are advancing the development, validation, and implementation of aging biomarkers through cutting-edge translational research.
Partners & Collaborators:
